We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$142M
AUM Growth
-$445K
Cap. Flow
-$1.24M
Cap. Flow %
-0.88%
Top 10 Hldgs %
76.61%
Holding
63
New
3
Increased
5
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
BDSX icon
Biodesix
BDSX
+$3.63M
2
ATEC icon
Alphatec Holdings
ATEC
+$806K
3
ELUT icon
Elutia
ELUT
+$608K
4
HALO icon
Halozyme
HALO
+$512K
5
PRTA icon
Prothena Corp
PRTA
+$483K

Top Sells

Rank Stock Value
1
CLR
CONTINENTAL RESOURCES INC.
CLR
+$2.58M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$1.12M
3
CCXI
ChemoCentryx, Inc.
CCXI
+$1.03M
4
NARI
Inari Medical, Inc. Common Stock
NARI
+$726K
5
VTYX
Ventyx Biosciences
VTYX
+$681K

Sector Composition

Rank Sector Weight
1 Healthcare 95.64%
2 Energy 4.26%
3 Consumer Staples 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STOK icon
51
Stoke Therapeutics
STOK
$1.73B
$138K 0.1%
15,000
– –
CNCE
52
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$117K 0.08%
20,000
– –
BHVN
53
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$102K 0.07%
7,365
-7,365
-50% -$1.12M
ELTX icon
54
Elicio Therapeutics
ELTX
$79.8M
$44K 0.03%
5,439
– –
YTEN
55
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$31K 0.02%
781
– –
AWH
56
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$20K 0.01%
4,005
– –
SIEN
57
DELISTED
Sientra, Inc.
SIEN
$8K 0.01%
4,000
– –
IRTC icon
58
iRhythm Holdings
IRTC
$3.66B
– –
-4,000
Closed -$501K
LSF icon
59
Laird Superfood
LSF
$47.1M
– –
-28,000
Closed -$51K
NARI
60
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-10,000
Closed -$726K
CLR
61
DELISTED
CONTINENTAL RESOURCES INC.
CLR
– –
-38,600
Closed -$2.58M
CCXI
62
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-20,000
Closed -$1.03M
CFRX
63
DELISTED
ContraFect Corporation
CFRX
– –
-2,500
Closed -$34K
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Birchview Capital held 63 positions worth $142M, down 0.31% from $142M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Birchview Capital's Q4 2022 filing shows 3 new, 5 increased, 7 reduced and 6 closed positions. Its largest new stake was Halozyme: 10,000 shares worth $569K. The largest sale was CONTINENTAL RESOURCES INC., an estimated $2.58M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 93% a quarter earlier, followed by Energy and Consumer Staples.

  • Birchview Capital's largest Q4 2022 buy was Halozyme: 10,000 shares worth $569K.
  • Birchview Capital added most to Biodesix in Q4 2022, an estimated $3.63M increase.
  • Birchview Capital's biggest Q4 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $1.12M.
  • Birchview Capital fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $2.58M.
  • Birchview Capital's ten largest holdings make up 77% of its $142M portfolio in Q4 2022.
  • Birchview Capital opened 3 new positions and closed 6 in Q4 2022.
  • Birchview Capital's portfolio value fell 0.31% quarter-over-quarter to $142M.

Based on Birchview Capital's 13F filing for Q4 2022, filed 3 Feb 2023.